Introduction {#s0001}
============

The removal of introns from RNA polymerase II-transcribed pre-mRNAs is catalyzed by the spliceosome, a large ribonucleoprotein complex assembled from 5 small nuclear ribonucleoprotein particles (snRNPs) and numerous protein factors.[@cit0001] Spliceosomes are assembled through a stepwise recruitment of snRNP and non-snRNP factors to pre-mRNA where the introns are defined by short conserved sequences, including the 5′ splice site, branch point, and 3′ splice site.[@cit0001] During assembly and the subsequent 2 catalytic steps of splicing, the spliceosome undergoes multiple rearrangements of its structure and composition, which involves both recruitment and release of individual factors.[@cit0001]

The *Saccharomyces cerevisiae* pre-mRNA retention and splicing (RES) complex is a heterotrimeric non-snRNP complex that associates with spliceosomes before the first catalytic step.[@cit0002] The RES complex is composed of Bud13p, Snu17p and Pml1p of which Snu17p is the core subunit that binds the other 2 factors.[@cit0002] RES factors are found in stoichiometric amounts in activated spliceosomes where they interact with intronic pre-mRNA sequences,[@cit0006] as well as with the U2 snRNP.[@cit0008] Homologues to the RES subunits are found in humans and these proteins also associate with spliceosomes before the first catalytic step.[@cit0012] In yeast, the RES complex is not essential for splicing as strains deleted for *BUD13, SNU17*, or *PML1* are viable.[@cit0002] Although genome-wide analyses of *bud13Δ* and *snu17Δ* strains revealed that they show increased accumulation of many intron-containing pre-mRNAs[@cit0014] direct tests have suggested that the RES complex preferentially promotes splicing of a subset of pre-mRNAs. The RES complex was originally proposed to enhance splicing of transcripts in which the 5′ splice site does not conform to the consensus sequence,[@cit0002] but more recent studies have shown that RES-regulated transcripts also include transcripts with consensus 5′ splice sites.[@cit0018] In addition to influencing splicing, the inactivation of any RES subunit leads to export of unspliced pre-mRNAs to the cytoplasm.[@cit0002] This finding in combination with the observation that the absence of Pml1p can, under some circumstances, induce pre-mRNA leakage without any apparent defect in splicing indicates that the RES complex may also have an important role in the nuclear retention of unspliced pre-mRNAs.[@cit0002]

The pre-mRNAs that enter the cytoplasm are typically degraded by the nonsense-mediated mRNA decay (NMD) pathway, as the presence of an intron often leads to the generation or inclusion of a premature translation termination codon.^21-^[@cit0024] The destabilization of transcripts containing premature translation termination codons requires their translation and a set of *trans*-acting factors, including the Upf1, Upf2, and Upf3 proteins.[@cit0025] By eliminating nonsense-containing transcripts, the NMD pathway ensures that protein-encoding transcripts encompass proper open reading frames (ORFs).[@cit0025]

Although the RES complex is dispensable for the growth of yeast cells, the inactivation of individual RES genes induces several different phenotypes. All 3 RES mutants show growth defects that are exacerbated at elevated temperatures but the cause of these phenotypes are not known.[@cit0002] The individual RES mutants show somewhat different growth phenotypes, i.e., cells deleted for *PML1* grow significantly better than cells deleted for *BUD13* or *SNU17* and *snu17Δ* mutants grow slightly better than *bud13Δ* cells.[@cit0002] As the splicing defects are more pronounced in *bud13Δ* and *snu17Δ* than in *pml1Δ* cells, the growth phenotypes of the individual mutants correlate to the importance of the respective factor in splicing.[@cit0002] In addition to the growth phenotypes, diploid cells deleted for *BUD13* or *SNU17* show a haploid-like bud-site selection pattern and an increased ability to mate as *MATα* cells.,[@cit0019] These phenotypes are caused by inefficient splicing of *MATa1* pre-mRNA and the consequent effect of reduced MATa1p levels on the ability to turn off haploid-specific genes and allow diploid gene expression.[@cit0018] Another phenotype associated with the absence of Bud13p or Snu17p is a severely reduced level of the modified nucleoside *N*^4^-acetylcytidine (ac^4^C) in tRNA.[@cit0020] At elevated temperatures, a reduction in ac^4^C levels is also observed in cells lacking Pml1p. This tRNA modification defect is caused by inefficient splicing of *TAN1* pre-mRNA[@cit0020] which encodes a tRNA binding protein required for formation of ac^4^C.[@cit0027] The absence of individual RES factors also leads to degradation of *TAN1* pre-mRNA by the cytoplasmic nonsense-mediated mRNA decay (NMD) pathway, indicating that poor nuclear retention may contribute to the tRNA modification defect.[@cit0020]

The notion that the RES complex enhances splicing of a distinct subset of pre-mRNAs suggests that the growth defects of RES mutants may be a consequence of inefficient processing of a specific transcript. To investigate this hypothesis, we screened for genes that in high dosage suppress the temperature sensitive (Ts) phenotype of *bud13Δ* cells. Here, we provide a detailed analysis of one dosage suppressor and show that the Ts phenotype of *bud13Δ* and *snu17Δ* mutants is largely a consequence of inefficient *MED20* pre-mRNA processing.

Results {#s0002}
=======

Increased dosage of the MED20 gene suppresses the Ts phenotype of bud13*Δ* and snu17*Δ* cells {#s0002-0001}
---------------------------------------------------------------------------------------------

To investigate the cause of the growth phenotypes of RES mutants, we screened for genes that in high dosage suppress the growth defect of *bud13Δ* cells at 37°C. Consistent with the notion that the growth defect may be a consequence of inefficient splicing of a specific transcript, we found that high-copy plasmids harboring the intron-containing *MED20* (*SRB2*) gene partially suppressed the Ts phenotype ([Fig. 1A](#f0001){ref-type="fig"}). The *MED20* gene harbors a 101 nt intron at the 5′ part of the ORF and codes for a nonessential subunit of the Mediator complex; an important co-regulator of RNA polymerase II transcription.[@cit0028] Cells deleted for *MED20* show growth defects that are similar to those observed for *bud13Δ* cells, i.e., they grow slowly and this phenotype is exacerbated at elevated temperatures[@cit0029] (Fig. S1). Figure 1.Increased dosage of the *MED20* gene suppresses the temperature sensitive growth defect of *bud13Δ* and *snu17Δ* mutants. (A) Growth of the wild-type (UMY2219) and *bud13Δ* (MJY546) strains carrying the indicated high-copy (h.c.) or low-copy (l.c.) *URA3* plasmids. The strains were grown over-night in liquid SC-ura medium, serially diluted, spotted on SC-ura plates, and incubated at 30°C or 37°C for 2 d. (B) Growth of the wild-type (UMY2219), *snu17Δ* (MJY548), and *pml1Δ* (MJY535) strains carrying the indicated plasmids. The strains were grown over-night in liquid SC-ura medium, serially diluted, spotted on SC-ura plates, and incubated at 30°C or 37°C for 2 d.

Individual RES mutants show somewhat different growth characteristics, i.e., cells lacking Pml1p grow considerably better than those lacking Bud13p or Snu17p and *snu17Δ* mutants grow slightly better than *bud13Δ* cells.[@cit0002] To assess if the suppression induced by increased *MED20* dosage is relevant for RES-deficient cells in general, we introduced the high-copy *MED20* plasmid into cells deleted for *SNU17* or *PML1*. Increased dosage of *MED20* partially suppressed the Ts phenotype of *snu17Δ* cells whereas no apparent suppression was observed for the *pml1Δ* mutant ([Fig. 1B](#f0001){ref-type="fig"}). Thus, the 2 RES mutants with the strongest growth defects are suppressed by increased *MED20* dosage.

Inefficient MED20 pre-mRNA splicing accounts for the Ts phenotype of bud13*Δ* and snu17*Δ* cells {#s0002-0002}
------------------------------------------------------------------------------------------------

To investigate if the RES complex is important for splicing of *MED20* pre-mRNA, we used northern blotting to analyze *MED20* transcripts in wild-type, *bud13Δ, snu17Δ*, and *pml1Δ* cells grown at 30°C or 37°C. The blots were also probed for the intron-less *PGK1* mRNA and 18S rRNA, which served as a loading control. The analyses revealed a decreased abundance of spliced and increased abundance of unspliced *MED20* transcripts in all 3 mutants ([Fig. 2A](#f0002){ref-type="fig"}). As expected, the splicing defect was more pronounced in the *bud13Δ* and *snu17Δ* mutants than in the *pml1Δ* strain at both 30°C and 37°C ([Fig. 2A and B](#f0002){ref-type="fig"}). The *MED20* mRNA level in the individual RES mutants was comparable at 30°C and 37°C, indicating that the growth temperature does not influence the efficiency of *MED20* pre-mRNA splicing. Figure 2.The RES complex promotes splicing of *MED20* pre-mRNA. (A) Northern analysis of total RNA isolated from wild-type (UMY2219), *bud13Δ* (MJY546), *snu17Δ* (MJY548), and *pml1Δ* (MJY535) cells grown in YEPD medium at 30°C or 37°C. The blot was probed for *MED20* and *PGK1* transcripts using randomly labeled DNA fragments. 18S rRNA was detected using an oligonucleotide probe. (B) Levels of spliced *MED20* mRNA in RES mutants. The *MED20* mRNA signal was normalized to the corresponding 18S rRNA signal and the value for each strain expressed relative to that for the wild-type at the same temperature, which was set to 100%. The *MED20* mRNA levels represent the average from the experiment shown in [Fig. 2A and 2](#f0002){ref-type="fig"} additional independent experiments. The standard deviation is indicated. (C) Western analysis of the indicated strains (MJY775, MJY779, MJY800, and MJY802) grown in YEPD medium at 30°C. Monoclonal antibodies against HA or Pgk1p were used to detect the indicated proteins. Control experiments showed that the sequence for the 3HA-tag did not influence the *MED20* pre-mRNA splicing efficiency in either wild-type or RES-deficient cells (data not shown). (D) Effects of the *MED20Δi* allele on growth of *bud13Δ, snu17Δ*, and *pml1Δ* cells. The wild-type (UMY2219), *MED20Δi* (MJY736), *bud13Δ* (MJY546), *bud13Δ MED20Δi* (MJY738), *snu17Δ* (MJY548), *snu17Δ MED20Δi* (MJY809), *pml1Δ* (MJY535), and *pml1Δ MED20Δi* (MJY808) strains were grown over-night in YEPD medium, serially diluted, spotted on YEPD plates, and incubated at 30°C or 37°C for 2 d.

To assess if the reduction in spliced *MED20* mRNA in the RES mutants correlates with reduced Med20 protein levels, we performed western blot analyses of strains in which the DNA sequence for 3 tandem influenza virus hemagglutinin epitopes (3HA) was fused to the endogenous *MED20* ORF. In good agreement with the mRNA levels, the abundance of Med20 protein was reduced in all 3 RES mutants and the Med20p levels were considerably lower in *bud13Δ* and *snu17Δ* than in *pml1Δ* cells ([Fig. 2C](#f0002){ref-type="fig"}). Thus, our results suggested a model where the Ts growth phenotypes of *bud13Δ* and *snu17Δ* cells are caused by inefficient *MED20* pre-mRNA splicing and the consequent reduction in Med20p levels.

If inefficient *MED20* pre-mRNA splicing contributes to the growth defect of *bud13Δ* and *snu17Δ* cells, then the growth defect should be suppressed by expressing an allele of *MED20* that lacks the intron. Because *pml1Δ* cells show only a modest growth defect, which is not suppressed by increased *MED20* dosage, the removal of the intron should have no or small effects. To test these predictions, we removed the sequence for the intron in the endogenous *MED20* gene and combined this *MED20Δi* allele with a *bud13Δ, snu17Δ*, or *pml1Δ* mutation. Northern blot analyses revealed that the introduction of the *MED20Δi* allele into the RES mutants generated *MED20* mRNA levels that were comparable to those normally observed in the wild-type (Fig. S2). As predicted, the growth defects of *bud13Δ* and *snu17Δ* cells at 37°C were largely suppressed by the *MED20Δi* allele whereas no effect was observed in *pml1Δ* cells ([Fig. 2D](#f0002){ref-type="fig"} and Table S1). The *MED20Δi* allele did, however, not counteract the growth defect of *bud13Δ* and *snu17Δ* cells at 30°C ([Fig. 2D](#f0002){ref-type="fig"} and Table S1), indicating that inefficient splicing of another transcript(s) determines the growth behavior at this temperature. We conclude that inefficient *MED20* pre-mRNA splicing is the primary cause for the Ts phenotype of *bud13Δ* and *snu17Δ* cells.

Inactivation of NMD in the RES mutants leads to accumulation of MED20 pre-mRNA {#s0002-0003}
------------------------------------------------------------------------------

In addition to its role in pre-mRNA splicing, the RES complex is thought to promote nuclear retention of unspliced pre-mRNAs.[@cit0002] Consistent with this notion, we previously showed that the absence of individual RES factors leads to degradation of *TAN1* pre-mRNA by the cytoplasmic NMD pathway.[@cit0020] The low total abundance of *MED20* transcripts in the RES mutants suggested that the *MED20* pre-mRNA may also be exported to the cytoplasm and degraded by NMD. To assess this possibility, we inactivated NMD by deleting the *UPF1* gene[@cit0031] and combined this *upf1Δ* allele with a *bud13Δ, snu17Δ*, or *pml1Δ* mutation. Unexpectedly, the Ts phenotype of *bud13Δ* and *snu17Δ* cells was partially suppressed by the inactivation of NMD whereas no apparent suppression was observed in the *pml1Δ* mutant ([Fig. 3A](#f0003){ref-type="fig"} and Table S1). Northern blotting was used to analyze the effect of NMD on the abundance of *MED20* transcripts in RES-deficient and RES-proficient cells. As controls, the blots were probed for the intron-containing *TAN1, GOT1* and *CYH2* transcripts. The latter 2 transcripts were selected because the abundance of *GOT1* pre-mRNA is largely unaffected by RES- and/or NMD-inactivation whereas the *CYH2* pre-mRNA is a well-characterized NMD substrate whose abundance is not influenced by the inactivation of RES factors..[@cit0020] The analyses revealed that the *MED20* pre-mRNA accumulates in NMD-deficient *bud13Δ, snu17Δ* and *pml1Δ* cells ([Fig. 3B](#f0003){ref-type="fig"}). Even though these findings suggest that RES inactivation leads to degradation of *MED20* pre-mRNA by the NMD pathway, the low abundance of *MED20* pre-mRNA in the *bud13Δ, snu17Δ* and *pml1Δ* single mutants prevented us from confirming that NMD directly influences its half-life. Figure 3.The inactivation of NMD in RES mutants causes accumulation of *MED20* pre-mRNA. (A) Effects of the *upf1Δ* allele on growth of *bud13Δ, snu17Δ*, and *pml1Δ* cells. The wild-type (UMY2219), *upf1Δ* (MJY537), *bud13Δ* (MJY546), *bud13Δ upf1Δ* (MJY555), *snu17Δ* (MJY548), *snu17Δ upf1Δ* (MJY557), *pml1Δ* (MJY535), and *pml1Δ upf1Δ* (MJY559) strains were grown over-night in YEPD medium, serially diluted, spotted on YEPD plates, and incubated at 30°C or 37°C for 2 d. (B) Northern analysis of total RNA isolated from wild-type (UMY2219), *upf1Δ* (MJY537), *bud13Δ* (MJY546), *bud13Δ upf1Δ* (MJY555), *snu17Δ* (MJY548), *snu17Δ upf1Δ* (MJY557), *pml1Δ* (MJY535), and *pml1Δ upf1Δ* (MJY559) cells grown in YEPD medium at 30°C. The blot was probed for *MED20, TAN1, CYH2, GOT1*, and *PGK1* transcripts using randomly labeled DNA fragments. 18S rRNA was detected using an oligonucleotide probe.

The first exon and the intron in MED20 are required for RES dependency {#s0002-0004}
----------------------------------------------------------------------

The RES complex was originally thought to be particularly important for splicing of transcripts that harbor introns with non-canonical 5′ splice sites.[@cit0002] However, more recent studies have shown that the RES-regulated transcripts also include transcripts with consensus 5′ splice sites.[@cit0018] In fact, we previously showed that the sequences between the 5′ splice site and branch point in *TAN1* pre-mRNA are necessary and sufficient to induce RES dependent splicing.[@cit0020] Although, the intron in *MED20* pre-mRNA encompasses canonical 5′ and 3′ splice sites, the branch site sequence differs at one position from the consensus. To determine if the non-canonical branch site is causing the RES dependency, we changed the branch site sequence in the endogenous *MED20* gene to the consensus. Analyses of wild-type, *upf1Δ, bud13Δ*, and *upf1Δ bud13Δ* cells harboring this allele (*MED20-BP\**) revealed that the transcript was still largely RES dependent ([Fig. 4A](#f0004){ref-type="fig"}). This finding suggested that some other feature(s) of *MED20* pre-mRNA induces the RES dependency. To assess if the intron is required, we replaced the endogenous *MED20* intron with the intron from the *GOT1* gene. The *MED20* pre-mRNA encompassing the *GOT1* intron was spliced more efficiently than both wild-type and branch site-altered *MED20* transcripts in *bud13Δ* and *upf1Δ bud13Δ* cells ([Fig. 4A](#f0004){ref-type="fig"}). Thus, the *MED20* intron encompasses a *cis*-acting feature that promotes RES dependency. Figure 4.RES-controlled splicing of *MED20* pre-mRNA requires both exonic and intronic elements. (A) Northern analysis of total RNA isolated from the indicated strains (UMY2219, MJY683, MJY546, MJY754, MJY817, MJY819, MJY821, MJY823 MJY735, MJY744, MJY746, and MJY748) grown in YEPD medium at 30°C. A schematic representation of the different *MED20* alleles is shown above the blot. The blot was probed for *MED20* transcripts using randomly labeled DNA fragments and for 18S rRNA using an oligonucleotide probe. (B) Northern analysis of total RNA isolated from the indicated strains (UMY2219, MJY683, MJY546, MJY754, MJY759, MJY761, MJY763, MJY765, MJY933, MJY934, MJY935, and MJY936) grown in YEPD medium at 30°C. A schematic representation of the different *GOT1* alleles is shown above the blot. The blot was probed for *GOT1* transcripts using randomly labeled DNA fragments and for 18S rRNA using an oligonucleotide probe.

To determine if the *MED20* intron is sufficient to trigger RES dependency, we replaced the intron in the endogenous *GOT1* gene with the intron from *MED20*. Although the abundance of the spliced *GOT1* transcript decreased in *bud13Δ* and *upf1Δ bud13Δ* cells, no accumulation of the hybrid pre-mRNA was observed ([Fig. 4B](#f0004){ref-type="fig"}). This finding indicated that *MED20* may also encompass a *cis*-acting element in an exon. To investigate the validity of this hypothesis, we replaced the first exon as well as the intron in *GOT1* with the corresponding sequences of *MED20*. The analyses revealed that the hybrid pre-mRNA accumulated in both *bud13Δ* and *upf1Δ bud13Δ* cells, indicating the presence of a *cis*-acting element in exon 1 of *MED20* ([Fig. 4B](#f0004){ref-type="fig"}). The lack of an effect of the *upf1Δ* allele on *MED20-GOT1* pre-mRNA abundance is due to the absence of a premature stop codon in the transcript, i.e., the pre-mRNA encompasses an ORF that begins at the *MED20* start codon and ends at the normal stop codon in *GOT1*. Collectively, these results indicate that the RES-dependent splicing of *MED20* pre-mRNA requires both exonic and intronic features.

Discussion {#s0003}
==========

The RES complex associates with spliceosomes and is thought to promote splicing of a subset of intron-containing pre-mRNAs. It has however been unclear if the growth defects of RES mutants are caused by inefficient splicing of specific transcripts or if they reflect a more general splicing defect. In this study, we find that the Ts phenotype of *bud13Δ* and *snu17Δ* cells is largely attributable to inefficient splicing of *MED20* pre-mRNA, which codes for a subunit of the Mediator complex. We also find that the *MED20* splicing defect is less pronounced in cells deleted for *PML1*, explaining why *pml1Δ* cells grow better than the other 2 RES mutants at 37°C. Thus, our findings suggest that the Ts phenotype of *bud13Δ* and *snu17Δ* mutants is caused by decreased Med20p levels and the consequent effects on the functionality of the Mediator complex.

Many factors that elicit their function at an early step of splicing also promote nuclear retention of unspliced pre-mRNAs. The effect on retention is usually not separable from that on splicing, but some factors, including Pml1p, have been suggested to promote nuclear retention without any apparent role in splicing.[@cit0002] Our finding that the inactivation of NMD in RES mutants leads to an accumulation of *MED20* pre-mRNA is consistent with the notion that the RES factors promote nuclear retention of unspliced pre-mRNAs.[@cit0002] However, the observation that *MED20* pre-mRNA accumulates in the *pml1Δ* single mutant makes it difficult to differentiate between effects on pre-mRNA retention and splicing.

Although the stabilization of unspliced pre-mRNAs in the cytoplasm is expected to be detrimental for growth, the inactivation of NMD in individual splicing factor mutants can lead to either enhanced or suppressed growth defects.[@cit0023] The mechanism by which the inactivation of NMD suppresses the growth defects of specific splicing factor mutants remains unknown.[@cit0034] The inactivation of NMD in the RES mutants causes a slight increase in the levels of spliced *MED20* mRNA ([Fig. 3B](#f0003){ref-type="fig"}), providing possible explanation to the finding that the Ts phenotype of *bud13Δ* and *snu17Δ* cells is partially suppressed by introduction of a *upf1Δ* allele. However, the *upf1Δ* allele also counteracts the growth defect of *bud13Δ* cells at 30°C, indicating that altered expression of other gene products contributes to the suppression.

In addition to *MED20*, 4 endogenous transcripts, *AMA1, MER2, MATa1* and *TAN1* are known to require Bud13p and Snu17p for efficient splicing[@cit0016] The *AMA1* and *MER2* pre-mRNAs are under control of the meiotic splicing regulator Mer1 and they both encompass an intron with a suboptimal 5´ splice site. In contrast, *MATa1, TAN1* and *MED20* contain introns with consensus 5´ splice sites, suggesting that the 5´ splice site may not be the defining feature for RES dependency. Accordingly, we previously showed that the sequence between the 5´ splice site and branch point is necessary and sufficient to induce RES-dependent splicing of *TAN1* pre-mRNA.[@cit0020] The *cis*-acting elements that induce RES dependency of *MED20* pre-mRNA are present in both the first exon and intron, suggesting that the defining element(s) may be different from that in *TAN1*. In the activated spliceosome, the RES complex interacts with intronic sequences down-stream of the branch site,[@cit0006] indicating that the *cis*-acting elements that trigger RES dependency may either represent sites where the RES complex initially interacts or they may indirectly influence the requirement for the RES factors. As the mechanism by which the RES complex preferentially enhances splicing of the target transcripts remains unclear, additional studies are needed to define the specificity and regulatory roles of the RES complex.

Materials and methods {#s0004}
=====================

Strains, media, and genetic procedures {#s0004-0001}
--------------------------------------

Yeast strains used in this study are listed in Table S2. Yeast transformations, media, and genetic procedures have been described.[@cit0035] Gene disruptions were confirmed by PCR using primers that annealed outside of sequences present in the transformed DNA fragment. Integrations of tags and sequences for altered introns were confirmed by DNA sequencing of the relevant PCR products.

A strain expressing a C-terminal 3HA-tagged Med20 protein was constructed by transforming the diploid strain UMY2366 with a *3HA-KanMX6* fragment amplified from pFA6a-*3HA-KanMX6.*[@cit0036] The oligonucleotides used were: 5′- ATGTGATTTGGCGTACCAGTATGTTCGTGCTCTGGAGCTGCGGATCCCCGGGTTAATTAA-3′ and 5′- CAAACAGAAAAAAAAAAAAAGAAAAAGCATTCGTAAGAACGAATTCGAGCTCGTTTAAAC-3′. The diploid strain was allowed to sporulate and a haploid *MED20::3HA-kanMX6* strain obtained from a tetrad. Strains MJY775, MJY779, MJY800, and MJY802 were obtained from subsequent crosses with the appropriate strains.

To construct strains expressing *MED20* transcripts in which the intron was removed, modified, or replaced, we first replaced the intron in one copy of *MED20* gene in the diploid strain UMY2366 with a *URA3* marker. The *URA3* marker was PCR-amplified from pRS406[@cit0037] using the oligonucleotides 5′- GCTCGAAAGCACAGTAGCAATCCATCATGGGAAAATCAGCAGATTGTACTGAGAGTGCAC-3′ and 5′- CGTTAGTGTAGCGGGAGTGGCTCTTTCCACGAATATAACGCTGTGCGGTATTTCACACCG-3′. The strain was allowed to sporulate and a haploid *med20::URA3* strain (MJY724) obtained from a tetrad. The haploid strain was transformed with DNA fragments containing the relevant sequence alterations and homologies to the exons of *MED20*. Following selection on 5-fluoroorotic acid (5-FOA)-containing plates, individual clones were screened for integration of the relevant DNA fragment. This approach combined with subsequent crosses with the appropriate strains generated MJY736, MJY738, MJY809, MJY808, MJY817, MJY819, MJY821, MJY823, MJY735, MJY744, MJY746, and MJY748. A similar approach was used to construct strains expressing hybrid *GOT1* transcripts. For these strains, MJY574 was transformed with the relevant DNA fragments. The generated strains were crossed to MJY696 and MJY759, MJY761, MJY763, MJY765, MJY933, MJY934, MJY935, MJY936 obtained from tetrads.

High copy suppressor screen {#s0004-0002}
---------------------------

To identify genes that in high dosage suppress the Ts phenotype of *bud13Δ* cells, we transformed strain MJY546 with a YEp24-based high copy genomic library[@cit0038] and selected for growth on SC-ura plates at 37°C. Plasmids from transformants that showed improved growth at 37°C were isolated and retransformed and those that stayed positive were partially sequenced and subjected to homology searches against the *S. cerevisiae* genome. The gene responsible for the suppression was identified by subclonings and retransformations.

Plasmid constructions {#s0004-0003}
---------------------

A high copy plasmid harboring the *MED20* gene (pMJ48) was constructed by cloning an EcoRI/KpnI DNA fragment from a suppressing YEp24 library plasmid into the corresponding sites of pRS426.[@cit0039] Plasmid pRS316-*BUD13* (pMJ51) has been described.[@cit0020]

RNA and protein methods {#s0004-0004}
-----------------------

RNA isolations and RNA gel blot analyses were performed as described .^20,40,41^ For western blotting experiments, ∼18 OD~600~ units of exponentially growing cells were harvested, washed once with buffer B (50 mM Tris-HCl at pH 7.5, 150 mM NaCl, 5% glycerol, 1 mM DTT), and resuspended in 250 µl buffer B containing 1 х protease inhibitor cocktail (Roche Applied Science). Samples were transferred to 2-ml tubes containing ∼0.15 g of glass beads (0.5 mm diameter, Biospec) and vortexed 6 times for 30 s with one minute on ice between steps. Following centrifugation, 15 µg of total protein was resolved by 10% SDS-PAGE and transferred to Immobilon-P membrane (Millipore). Proteins were detected as described previously.[@cit0020]
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